Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2001
11/29/2001WO2001089518A1 Method of determining a dosage of anti-oxidant for an individual
11/29/2001WO2001089510A2 Use of an ampa receptor potentiator for the treatment of obesity
11/29/2001WO2001089494A2 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
11/29/2001WO2001089451A2 Protease inhibitors
11/29/2001WO2001089319A2 Tryptophan source from plants and uses therefor
11/29/2001WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001WO2001060835A8 Purine derivatives
11/29/2001WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001WO2001049674A3 Glycosidase inhibitors and preparation thereof
11/29/2001WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof
11/29/2001WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001WO2001038566A3 Screening method for candidate drugs
11/29/2001WO2001035096A3 Diseases associated with altered mitochondrial function
11/29/2001WO2001028567A3 Aminoalkylenephosphonates for treatment of bone disorders
11/29/2001WO2000055159A3 Substituted aza-oxindole derivatives
11/29/2001WO2000047104A9 Antagonists of hmg1 for treating inflammatory conditions
11/29/2001WO2000040722A3 Insulin-synthesis genes
11/29/2001WO2000039114A3 Substituted oximes and hydrazones as neurokinin antagonists
11/29/2001WO2000038666A3 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES
11/29/2001WO2000010548A3 19-nor-vitamin d3 compounds with calcemic activity
11/29/2001US20010047084 Extendin derivatives
11/29/2001US20010047035 Detecton, treatment and monitoring the patient with poor wound healing ability due to diabetes based on measurement of the breakdown product of nitric oxide (NO) in specimens taken from the patient under controlled conditions
11/29/2001US20010047030 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
11/29/2001US20010047008 Allosteric adenosine receptor modulators
11/29/2001US20010047002 Squarate derivatives of dihydropyridine NPY antagonists
11/29/2001US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
11/29/2001US20010046963 Inhibiting cyclooxygenase-2 biosynthesis and Nuclear factor kappa B synthesis; treatment of arthritis and Alzheimer's disease; administering in food
11/29/2001US20010046958 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
11/29/2001US20010046956 May contain another compound to treat diabetes, sexual dysfunction, atherosclerosis, insulin resistance, impaired glucose tolerance, hypercholesterolemia or hypertriglyceridemia
11/29/2001US20010046533 With natural isomers of reduced folate such as 5-methyl-6(S)-tetrahydrofolic acid, a food preparation, and/or essential nutrient preparation (other than ascorbic acid) in given molar amounts
11/29/2001US20010046496 Administering to the human having a disease associated with leukocyte infiltration of mucosal tissues a humanized immunoglobulin or antigen-binding fragment having binidng specificity for alpha 4 beta 7 integrain
11/29/2001US20010046495 Use of cross-linked, covalently bound urokinase plasminogen activator (scuPAR)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent
11/29/2001US20010046490 Cell surface molecule-induced macrophage activation
11/29/2001US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
11/29/2001EP1143949A3 19-nor-vitamin d3 compounds with calcemic activity
11/29/2001DE10024939A1 Neue Diphenylmethanderivate für Arzneimittel New diphenylmethane derivatives for pharmaceuticals
11/29/2001CA2429199A1 Drug metabolizing enzymes
11/29/2001CA2410563A1 Methods for preventing strokes by inducing tolerance to e-selectin
11/29/2001CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001CA2410338A1 Tyrosine phosphatase inhibitors
11/29/2001CA2409956A1 Use of ciliary neurotrophic factor
11/29/2001CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001CA2408783A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001CA2408562A1 Dehydroascorbic acid formulations and uses thereof
11/29/2001CA2408141A1 Neurotransmitter transporters
11/29/2001CA2408140A1 G-protein coupled receptors
11/29/2001CA2408036A1 Combination of growth hormone secretagogues and antidepressants
11/29/2001CA2407964A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001CA2406829A1 Protease inhibitors
11/29/2001CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001EP1158002A1 Human G-protein coupled receptor
11/28/2001EP1157992A1 Dihydro-2,3-Benzodiazepine derivatives
11/28/2001EP1157697A1 Remedies for hyperammonemia
11/28/2001EP1157696A2 Treatment of rumen acidosis with alpha-amylase inhibitors
11/28/2001EP1157695A1 Method of treating obesity using a neurotensin receptor ligand
11/28/2001EP1157104A2 Pyk2 binding proteins
11/28/2001EP1157043A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
11/28/2001EP1157040A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
11/28/2001EP1157024A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/28/2001EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001EP1157014A1 Polycyclic 2-amino-dihydrothiazole systems, method for the production thereof and their utilization as medicament
11/28/2001EP1157013A1 Polycyclic thiazole-2-ylides amines, method for the production thereof and their utilization as medicaments
11/28/2001EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001EP1157000A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/28/2001EP1156999A1 Method for the preparation of a chiral-beta-amino ester
11/28/2001EP1156820A1 Vascular endothelial growth factor-2
11/28/2001EP1156795A1 Use of succinic acid or salts thereof and method of treating insulin resistance
11/28/2001EP1156771A2 Interferon tau mutants and methods for making them
11/28/2001EP0914129B1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents
11/28/2001EP0804469B1 T-cell affecting peptides
11/28/2001EP0770068B1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents
11/28/2001EP0512076B1 Method of treating cancer using structured lipids
11/28/2001CN1324400A Method of screening for large offspring syndrome
11/28/2001CN1324360A Bicyclic nitrogen heterocycles
11/28/2001CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001CN1324350A Benzoylpyridazines
11/28/2001CN1323794A Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
11/28/2001CN1323625A Hypolycemic traditional Chinese medicine composite
11/28/2001CN1323621A Hypolycemic pellet made of ginseng and largehead atractylodes rhizome
11/28/2001CN1323601A Diebestos treating medicine
11/28/2001CN1323581A Calcium making-up agent material
11/27/2001US6323242 Treatment of disorders secondary to organic impairments
11/27/2001US6323232 Combination therapy for osteoporosis
11/27/2001US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001US6323225 Pharmaceutical composition
11/27/2001US6323214 Allosteric adenosine receptor modulators
11/27/2001US6323192 Chromium polynicotinate compositions and uses thereof for absorption of essential metals
11/27/2001US6323178 Beta-lipotropin methods
11/27/2001US6323029 Therapeutic, diagnostic, and research applications for the modulation of glycogen synthase kinase 3 beta expression
11/27/2001US6322976 Compositions and methods of disease diagnosis and therapy
11/27/2001US6322806 Over-coated chewing gum formulations including tableted center
11/27/2001US6322784 Glucocorticoid, a compound which stimulates camp production and compound which upregulates peroxisome proliferator activated receptor .gamma. expression
11/27/2001CA2179712C Crosslinked polymeric ammonium salts
11/27/2001CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals
11/25/2001CA2309518A1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/22/2001WO2001088533A2 Lipid uptake assays
11/22/2001WO2001088532A2 Improved assay techniques using nematode worms